Interestingly, although plasma apoE is unable to cross the blood–brain barrier [5], we have also found that a higher ratio of plasma apoE4 to apoE3 levels was linked to negative brain imaging findings including gray matter atrophy and lower cerebral glucose metabolism [15], worse cognition, and more pathological CSF AD biomarker levels [16]. The gene discussed is APOE; the disease is Alzheimer disease.